On Eve Of Plavix Trial, Apotex Suffers Another Blow
The U.S. Court of Appeals for the Federal Circuit has once again handed a setback to Apotex Inc. in its Plavix patent spat with Sanofi-Aventis and Bristol-Myers Squibb Co., denying the...To view the full article, register now.
Already a subscriber? Click here to view full article